张小丰2017-11-09 14:03
$AnaptysBio, Inc.(ANAB)$ $再生元制药(REGN)$
IL-33这个靶点要来真的有前途。最近ANAB的早期数据出来直接当天暴涨了100%。。再生元也会全力推进这个项目,还有和Dupliumab组合使用的潜力。
Leonard S. Schleifer:
this is a really exciting target for us for many reasons, one ...查看全文
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-020034 Size: 6 KB 网页链接
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-020036 Size: 6 KB 网页链接
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-020039 Size: 6 KB 网页链接
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-020031 Size: 6 KB 网页链接
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019829 Size: 9 KB 网页链接
$AnaptysBio(ANAB)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005507 Act: 33 Size: 4 KB 网页链接
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019676 Size: 11 KB 网页链接
$AnaptysBio(ANAB)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005377 Act: 33 Size: 5 KB 网页链接
$AnaptysBio(ANAB)$ SC 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-24-001841 Act: 34 Size: 8 KB 网页链接
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018032 Size: 4 KB 网页链接